SCHEMBL13706264

SCHEMBL13706264

c1ccc(-c2cc3ccccc3cc2-c2ccc3c4c(cccc24)-c2cc(-c4cnccn4)ccc2-3)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.41
ALOX5AP P20292 2/20 0.39
FEN1 P39748 2/20 0.39
PIM2 Q9P1W9 3/20 0.39
ALDH1A1 P00352 3/20 0.38
HPGD P15428 3/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 2/20 0.38
CASP1 P29466 2/20 0.38
HIF1A Q16665 2/20 0.38
HSD17B10 Q99714 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SIRT2 Q8IXJ6 1/20 0.38
CYP11B1 P15538 2/20 0.37
PIM1 P11309 3/20 0.37
PIM3 Q86V86 1/20 0.36
SCN9A Q15858 1/20 0.36
HASPIN Q8TF76 1/20 0.36
TP53 P04637 1/20 0.36
CASP7 P55210 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13706263 0.87 HSD17B10 (0.41) TNFALDH1A1HPGDTSHRMAPK1
SCHEMBL30128471 0.79 ALOX5AP (0.48) ALOX5APFEN1PIM2ALDH1A1TSHR
SCHEMBL25595938 0.79 ALDH1A1 (0.47) TNFALDH1A1HPGDTSHRMAPK1
SCHEMBL25595942 0.78 HPGD (0.45) ALDH1A1HPGDTSHRMAPK1CASP1
SCHEMBL25595946 0.78 HPGD (0.45) ALDH1A1HPGDTSHRMAPK1CASP1
SCHEMBL12236497 0.77 HPGD (0.46) TNFALOX5APFEN1PIM2ALDH1A1
SCHEMBL25596019 0.77 ALDH1A1 (0.46) TNFALDH1A1HPGDTSHRMAPK1
SCHEMBL19768149 0.75 ALOX5AP (0.37) ALOX5APFEN1PIM2ALDH1A1HPGD
SCHEMBL17692189 0.75 TNF (0.61) TNFALDH1A1HPGDTSHRMAPK1
SCHEMBL25595936 0.74 ALDH1A1 (0.49) TNFALDH1A1HPGDTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-09-17 US disclosed
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090230852-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OXER1, L1CAM, RPL41 TNF 4644/4885ALOX5AP 2210/4885FEN1 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.